Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2025-12-28 @ 6:44 PM
Study NCT ID:
NCT01476657
Status:
TERMINATED
Last Update Posted:
2021-03-17
First Post:
2011-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of Duvelisib in Patients With Advanced Hematologic Malignancies
Sponsor:
SecuraBio
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-10
Start Date Type:
None
Primary Completion Date:
2016-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-01
Completion Date Type:
ACTUAL
First Submit Date:
2011-11-17
First Submit QC Date:
None
Study First Post Date:
2011-11-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-15
Last Update Post Date:
2021-03-17
Last Update Post Date Type:
ACTUAL